Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 691

1.

Publisher Correction: α-SNAP is expressed in mouse ovarian granulosa cells and plays a key role in folliculogenesis and female fertility.

Arcos A, de Paola M, Gianetti D, Acuña D, Velásquez ZD, Miró MP, Toro G, Hinrichsen B, Muñoz RI, Lin Y, Mardones GA, Ehrenfeld P, Rivera FJ, Michaut MA, Batiz LF.

Sci Rep. 2020 Mar 25;10(1):5691. doi: 10.1038/s41598-020-61863-w.

2.

Inactivation of helminth eggs in an electro-Fenton reactor: Towards full electrochemical disinfection of human waste using activated carbon.

Robles I, Becerra E, Barrios JA, Maya C, Jiménez B, Rodríguez-Valadez FJ, Rivera F, García-Espinoza JD, Godínez LA.

Chemosphere. 2020 Feb 18;250:126260. doi: 10.1016/j.chemosphere.2020.126260. [Epub ahead of print]

3.

Results of REARRANGE trial: A randomized phase 2 study comparing different dosing approaches for regorafenib (REG) during the first cycle of treatment in patients (pts) with metastatic colorectal cancer (mCRC).

Argiles G, Margalef NM, Valladares-Ayerbes M, de Prado JV, Grávalos C, Alfonso PG, Santos C, Tobeña M, Sastre J, Benavides M, Cano T, Loupakis F, Garrote MR, Rivera F, Goldberg R, Falcone A, Bennouna J, Ciardiello F, Tabernero J, Aranda E.

Ann Oncol. 2019 Jul;30 Suppl 4:iv135. doi: 10.1093/annonc/mdz154.025. Epub 2019 Dec 4. No abstract available.

PMID:
32085044
4.

Is aflibercept an optimal treatment for wt RAS mCRC patients after progression to first line containing anti-EGFR?

Vera R, Mata E, González E, Juez I, Alonso V, Iranzo P, Martínez NP, López C, Cabrera JM, Safont MJ, Ruiz-Casado A, Salgado M, González B, Escudero P, Rivera F, Pericay C.

Int J Colorectal Dis. 2020 Apr;35(4):739-746. doi: 10.1007/s00384-020-03509-x. Epub 2020 Feb 15.

PMID:
32062727
5.

Opioid Use in Fibromyalgia Continues Despite Guidelines That Do Not Support Its Efficacy or Risk.

Bruce BK, Allman ME, Rivera FA, Abril A, Gehin JM, Oliphant LM, Nordan LM, White LJ, Martinez D, Niazi SK.

J Clin Rheumatol. 2020 Feb 6. doi: 10.1097/RHU.0000000000001273. [Epub ahead of print]

PMID:
32040055
6.

Communication Challenges Among Oncologists in Mexico.

Platas A, Cruz-Ramos M, Mesa-Chavez F, Jasqui-Bucay A, de la Rosa-Pacheco S, Rivera F, Mohar A, Villarreal-Garza C.

J Cancer Educ. 2020 Feb 6. doi: 10.1007/s13187-020-01703-7. [Epub ahead of print]

PMID:
32030611
7.

SEOM clinical guideline for the diagnosis and treatment of gastric cancer (GC) and gastroesophageal junction adenocarcinoma (GEJA) (2019).

Martín-Richard M, Carmona-Bayonas A, Custodio AB, Gallego J, Jiménez-Fonseca P, Reina JJ, Richart P, Rivera F, Alsina M, Sastre J.

Clin Transl Oncol. 2020 Feb;22(2):236-244. doi: 10.1007/s12094-019-02259-9. Epub 2020 Jan 27.

PMID:
31989475
8.

[Supervision of clinical trials in Social Health Insurance at Peruvian Hospitals: administrative and regulatory approach].

García-Mostajo JA, Rivera FP, Alvarez-Arroyo V, Catacora-Villasante M, Acosta J.

Rev Peru Med Exp Salud Publica. 2019 Oct-Dec;36(4):687-691. doi: 10.17843/rpmesp.2019.364.4569. Epub 2020 Jan 17. Spanish.

PMID:
31967263
9.

Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR Group.

André T, Vernerey D, Im SA, Bodoky G, Buzzoni R, Reingold S, Rivera F, McKendrick J, Scheithauer W, Ravit G, Fountzilas G, Yong WP, Isaacs R, Österlund P, Liang JT, Creemers GJ, Rakez M, Van Cutsem E, Cunningham D, Tabernero J, de Gramont A.

Ann Oncol. 2020 Feb;31(2):246-256. doi: 10.1016/j.annonc.2019.12.006. Epub 2019 Dec 18.

PMID:
31959341
10.

Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study.

Philip PA, Lacy J, Portales F, Sobrero A, Pazo-Cid R, Manzano Mozo JL, Kim EJ, Dowden S, Zakari A, Borg C, Terrebonne E, Rivera F, Sastre J, Bathini V, López-Trabada D, Asselah J, Saif MW, Shiansong Li J, Ong TJ, Nydam T, Hammel P.

Lancet Gastroenterol Hepatol. 2020 Mar;5(3):285-294. doi: 10.1016/S2468-1253(19)30327-9. Epub 2020 Jan 14.

PMID:
31953079
11.

Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE).

Kundranda M, Gracian AC, Zafar SF, Meiri E, Bendell J, Algül H, Rivera F, Ahn ER, Watkins D, Pelzer U, Charu V, Zalutskaya A, Kuesters G, Pipas JM, Santillana S, Askoxylakis V, Ko AH.

Ann Oncol. 2020 Jan;31(1):79-87. doi: 10.1016/j.annonc.2019.09.004.

PMID:
31912800
12.

Extracellular Vesicles Can Deliver Anti-inflammatory and Anti-scarring Activities of Mesenchymal Stromal Cells After Spinal Cord Injury.

Romanelli P, Bieler L, Scharler C, Pachler K, Kreutzer C, Zaunmair P, Jakubecova D, Mrowetz H, Benedetti B, Rivera FJ, Aigner L, Rohde E, Gimona M, Strunk D, Couillard-Despres S.

Front Neurol. 2019 Nov 29;10:1225. doi: 10.3389/fneur.2019.01225. eCollection 2019.

13.

Dimethylsulfoxide Inhibits Oligodendrocyte Fate Choice of Adult Neural Stem and Progenitor Cells.

O'Sullivan A, Lange S, Rotheneichner P, Bieler L, Aigner L, Rivera FJ, Couillard-Despres S.

Front Neurosci. 2019 Nov 26;13:1242. doi: 10.3389/fnins.2019.01242. eCollection 2019.

14.

Dual caregiving by grandmothers with older relatives: Personal factors influencing health and stress.

Luna S, Rivera F, Ramos P.

J Health Psychol. 2019 Dec 18:1359105319893112. doi: 10.1177/1359105319893112. [Epub ahead of print]

PMID:
31849235
15.

[Trends in alcohol consumption among school-aged adolescents in Spain (2010-2018)].

Leal-López E, Sánchez-Queija I, Rivera F, Moreno C.

Gac Sanit. 2019 Nov 27. pii: S0213-9111(19)30223-7. doi: 10.1016/j.gaceta.2019.07.011. [Epub ahead of print] Spanish.

16.

Influence of the Sense of Coherence, the Doctor-Patient Relationship, Optimism and Non-Haematological Adverse Reactions on Health-Related Quality of Life in Patients with Breast Cancer.

Prieto-Callejero B, Rivera F, Andrés-Villas M, Gómez-Salgado J.

J Clin Med. 2019 Nov 21;8(12). pii: E2043. doi: 10.3390/jcm8122043.

17.

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort: Under the Auspices of the EAU-ESMO Guidelines Committees.

Witjes JA, Babjuk M, Bellmunt J, Bruins HM, De Reijke TM, De Santis M, Gillessen S, James N, Maclennan S, Palou J, Powles T, Ribal MJ, Shariat SF, Der Kwast TV, Xylinas E, Agarwal N, Arends T, Bamias A, Birtle A, Black PC, Bochner BH, Bolla M, Boormans JL, Bossi A, Briganti A, Brummelhuis I, Burger M, Castellano D, Cathomas R, Chiti A, Choudhury A, Compérat E, Crabb S, Culine S, De Bari B, De Blok W, J L De Visschere P, Decaestecker K, Dimitropoulos K, Dominguez-Escrig JL, Fanti S, Fonteyne V, Frydenberg M, Futterer JJ, Gakis G, Geavlete B, Gontero P, Grubmüller B, Hafeez S, Hansel DE, Hartmann A, Hayne D, Henry AM, Hernandez V, Herr H, Herrmann K, Hoskin P, Huguet J, Jereczek-Fossa BA, Jones R, Kamat AM, Khoo V, Kiltie AE, Krege S, Ladoire S, Lara PC, Leliveld A, Linares-Espinós E, Løgager V, Lorch A, Loriot Y, Meijer R, Mir MC, Moschini M, Mostafid H, Müller AC, Müller CR, N'Dow J, Necchi A, Neuzillet Y, Oddens JR, Oldenburg J, Osanto S, J G Oyen W, Pacheco-Figueiredo L, Pappot H, Patel MI, Pieters BR, Plass K, Remzi M, Retz M, Richenberg J, Rink M, Roghmann F, Rosenberg JE, Rouprêt M, Rouvière O, Salembier C, Salminen A, Sargos P, Sengupta S, Sherif A, Smeenk RJ, Smits A, Stenzl A, Thalmann GN, Tombal B, Turkbey B, Lauridsen SV, Valdagni R, Van Der Heijden AG, Van Poppel H, Vartolomei MD, Veskimäe E, Vilaseca A, Rivera FAV, Wiegel T, Wiklund P, Williams A, Zigeuner R, Horwich A.

Eur Urol. 2020 Feb;77(2):223-250. doi: 10.1016/j.eururo.2019.09.035. Epub 2019 Nov 19.

PMID:
31753752
18.

Situation, challenges, and SEOM recommendations for the future of undergraduate education in Oncology in Spain.

Segui MA, Cruz JJ, Alba E, Feliu J, Jara C, Rivera F, Rodriguez Lescure A, Lorenzo A, Martin M.

Clin Transl Oncol. 2019 Nov 8. doi: 10.1007/s12094-019-02230-8. [Epub ahead of print] Review.

PMID:
31701365
19.

Improvement in Heavy Metal Removal from Wastewater Using an External Magnetic Inductor.

Rivera FL, Palomares FJ, Herrasti P, Mazario E.

Nanomaterials (Basel). 2019 Oct 23;9(11). pii: E1508. doi: 10.3390/nano9111508.

20.

HIV/AIDS stigma manifestations during clinical interactions with MSM in Puerto Rico.

Varas-Díaz N, Rivera-Segarra E, Neilands TB, Carminelli-Corretjer P, Rivera F, Varas-Rodríguez E, Ortiz N, Pedrogo Y, Díaz MR.

J Gay Lesbian Soc Serv. 2019;31(2):141-152. doi: 10.1080/10538720.2018.1548325. Epub 2019 May 6.

PMID:
31588167
21.

Correction to: Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial.

Rivera F, Romero C, Jimenez-Fonseca P, Izquierdo-Manuel M, Salud A, Martínez E, Jorge M, Arrazubi V, Méndez JC, García-Alfonso P, Reboredo M, Barriuso J, Muñoz-Unceta N, Jimeno R, López C.

Cancer Chemother Pharmacol. 2019 Dec;84(6):1365. doi: 10.1007/s00280-019-03964-6.

22.

Loss of complement regulatory proteins on red blood cells in mild malarial anaemia and in Plasmodium falciparum induced blood-stage infection.

Oyong DA, Loughland JR, SheelaNair A, Andrew D, Rivera FDL, Piera KA, William T, Grigg MJ, Barber BE, Haque A, Engwerda CR, McCarthy JS, Anstey NM, Boyle MJ.

Malar J. 2019 Sep 18;18(1):312. doi: 10.1186/s12936-019-2962-0.

23.

Relationship Between Tumor Response and Tumor-Related Symptoms in RAS Wild-Type Metastatic Colorectal Cancer: Retrospective Analyses From 3 Panitumumab Trials.

Taieb J, Geissler M, Rivera F, Karthaus M, Wilson R, Loupakis F, Price T, Tracy M, Burdon P, Peeters M.

Clin Colorectal Cancer. 2019 Dec;18(4):245-256.e5. doi: 10.1016/j.clcc.2019.07.009. Epub 2019 Jul 29.

24.

The Role of Body Image in Internalizing Mental Health Problems in Spanish Adolescents: An Analysis According to Sex, Age, and Socioeconomic Status.

Ramos P, Moreno-Maldonado C, Moreno C, Rivera F.

Front Psychol. 2019 Aug 22;10:1952. doi: 10.3389/fpsyg.2019.01952. eCollection 2019.

25.

Effect of electrode geometry on the electrolyte resistance measurement over the surface of a skin phantom in a noninvasive manner.

Delgado-Arenas HF, Rodríguez-López A, Rivera F, Ramos KJ, Reséndiz-Ramírez R, Antano-Lopez R.

Bioelectrochemistry. 2019 Dec;130:107337. doi: 10.1016/j.bioelechem.2019.107337. Epub 2019 Jul 24.

PMID:
31400566
26.

Some environmental and biological determinants of coral richness, resilience and reef building in Galápagos (Ecuador).

Riegl B, Johnston M, Glynn PW, Keith I, Rivera F, Vera-Zambrano M, Banks S, Feingold J, Glynn PJ.

Sci Rep. 2019 Jul 16;9(1):10322. doi: 10.1038/s41598-019-46607-9.

27.

Prognosis of urinary tract infection caused by KPC-producing Klebsiella pneumoniae: The impact of inappropriate empirical treatment.

Rodriguez-Gómez J, Pérez-Nadales E, Gutiérrez-Gutiérrez B, Machuca I, Martinez-Martinez L, Rivera F, Cano A, Castón JJ, Robles JC, de la Fuente C, Rodríguez-López F, Rodriguez-Baño J, Torre-Cisneros J; Spanish Network for Research in Infectious Diseases (REIPI), Instituto de Salud Carlos III, Madrid, Spain.

J Infect. 2019 Sep;79(3):245-252. doi: 10.1016/j.jinf.2019.06.014. Epub 2019 Jul 2.

PMID:
31276705
28.

Pericytes in Multiple Sclerosis.

Rivera FJ, Hinrichsen B, Silva ME.

Adv Exp Med Biol. 2019;1147:167-187. doi: 10.1007/978-3-030-16908-4_8.

PMID:
31147878
29.

Expression of DDR1 in the CNS and in myelinating oligodendrocytes.

Vilella E, Gas C, Garcia-Ruiz B, Rivera FJ.

Biochim Biophys Acta Mol Cell Res. 2019 Nov;1866(11):118483. doi: 10.1016/j.bbamcr.2019.04.010. Epub 2019 May 18. Review.

PMID:
31108116
30.

Direct and Indirect Influences of Objective Socioeconomic Position on Adolescent Health: The Mediating Roles of Subjective Socioeconomic Status and Lifestyles.

Moreno-Maldonado C, Ramos P, Moreno C, Rivera F.

Int J Environ Res Public Health. 2019 May 10;16(9). pii: E1637. doi: 10.3390/ijerph16091637.

31.

Aging restricts the ability of mesenchymal stem cells to promote the generation of oligodendrocytes during remyelination.

Rivera FJ, de la Fuente AG, Zhao C, Silva ME, Gonzalez GA, Wodnar R, Feichtner M, Lange S, Errea O, Priglinger E, O'Sullivan A, Romanelli P, Jadasz JJ, Brachtl G, Greil R, Tempfer H, Traweger A, Bátiz LF, Küry P, Couillard-Despres S, Franklin RJM, Aigner L.

Glia. 2019 Aug;67(8):1510-1525. doi: 10.1002/glia.23624. Epub 2019 Apr 30.

32.

Pericytes Favor Oligodendrocyte Fate Choice in Adult Neural Stem Cells.

Silva ME, Lange S, Hinrichsen B, Philp AR, Reyes CR, Halabi D, Mansilla JB, Rotheneichner P, Guzman de la Fuente A, Couillard-Despres S, Bátiz LF, Franklin RJM, Aigner L, Rivera FJ.

Front Cell Neurosci. 2019 Mar 27;13:85. doi: 10.3389/fncel.2019.00085. eCollection 2019.

33.

Pericytes in the Retina.

Trost A, Bruckner D, Rivera FJ, Reitsamer HA.

Adv Exp Med Biol. 2019;1122:1-26. doi: 10.1007/978-3-030-11093-2_1. Review.

PMID:
30937860
34.

Purification, structural elucidation, antioxidant capacity and neuroprotective potential of the main polyphenolic compounds contained in Achyrocline satureioides (Lam) D.C. (Compositae).

Martínez-Busi M, Arredondo F, González D, Echeverry C, Vega-Teijido MA, Carvalho D, Rodríguez-Haralambides A, Rivera F, Dajas F, Abin-Carriquiry JA.

Bioorg Med Chem. 2019 Jun 15;27(12):2579-2591. doi: 10.1016/j.bmc.2019.03.047. Epub 2019 Mar 25.

PMID:
30935792
35.

Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial.

Rivera F, Romero C, Jimenez-Fonseca P, Izquierdo-Manuel M, Salud A, Martínez E, Jorge M, Arrazubi V, Méndez JC, García-Alfonso P, Reboredo M, Barriuso J, Muñoz-Unceta N, Jimeno R, López C.

Cancer Chemother Pharmacol. 2019 Jun;83(6):1175-1181. doi: 10.1007/s00280-019-03820-7. Epub 2019 Mar 29. Erratum in: Cancer Chemother Pharmacol. 2019 Dec;84(6):1365.

36.

Role of adherens junctions and apical-basal polarity of neural stem/progenitor cells in the pathogenesis of neurodevelopmental disorders: a novel perspective on congenital Zika syndrome.

Bustamante FA, Miró MP, VelÁsquez ZD, Molina L, Ehrenfeld P, Rivera FJ, BÁtiz LF.

Transl Res. 2019 Aug;210:57-79. doi: 10.1016/j.trsl.2019.02.014. Epub 2019 Mar 5. Review.

PMID:
30904442
37.

Interleukin 2 is an Upstream Regulator of CD4+ T Cells From Visceral Leishmaniasis Patients With Therapeutic Potential.

Chauhan SB, Faleiro R, Kumar R, Ng S, Singh B, Singh OP, Singh SS, Amante F, Rivera FL, Rai M, Chakravarty J, Sacks D, Nylen S, Sundar S, Engwerda C.

J Infect Dis. 2019 Jun 5;220(1):163-173. doi: 10.1093/infdis/jiz074.

PMID:
30796820
38.

Pre-clinical development of Listeria-based nanovaccines as immunotherapies for solid tumours: insights from melanoma.

Terán-Navarro H, Calderon-Gonzalez R, Salcines-Cuevas D, García I, Marradi M, Freire J, Salmon E, Portillo-Gonzalez M, Frande-Cabanes E, García-Castaño A, Martinez-Callejo V, Gomez-Roman J, Tobes R, Rivera F, Yañez-Diaz S, Álvarez-Domínguez C.

Oncoimmunology. 2018 Nov 10;8(2):e1541534. doi: 10.1080/2162402X.2018.1541534. eCollection 2019.

39.

Use of a Dual mobility cup to prevent hip early arthroplasty dislocation in patients at high falls risk.

Nonne D, Sanna F, Bardelli A, Milano P, Rivera F.

Injury. 2019 Aug;50 Suppl 4:S26-S29. doi: 10.1016/j.injury.2019.01.022. Epub 2019 Jan 18.

PMID:
30691923
40.

Panitumumab-based maintenance after oxaliplatin discontinuation in metastatic colorectal cancer: A retrospective analysis of two randomised trials.

Modest DP, Rivera F, Bachet JB, de Braud F, Pietrantonio F, Koukakis R, Demonty G, Douillard JY.

Int J Cancer. 2019 Jul 15;145(2):576-585. doi: 10.1002/ijc.32110. Epub 2019 Jan 24.

41.

Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2.

Macarulla T, Pazo-Cid R, Guillén-Ponce C, López R, Vera R, Reboredo M, Muñoz Martin A, Rivera F, Díaz Beveridge R, La Casta A, Martín Valadés J, Martínez-Galán J, Ales I, Sastre J, Perea S, Hidalgo M.

J Clin Oncol. 2019 Jan 20;37(3):230-238. doi: 10.1200/JCO.18.00089. Epub 2018 Dec 4.

PMID:
30523758
42.

Tumor treating fields in combination with gemcitabine or gemcitabine plus nab-paclitaxel in pancreatic cancer: Results of the PANOVA phase 2 study.

Rivera F, Benavides M, Gallego J, Guillen-Ponce C, Lopez-Martin J, Küng M.

Pancreatology. 2019 Jan;19(1):64-72. doi: 10.1016/j.pan.2018.10.004. Epub 2018 Oct 17.

43.

Age Influences Microglial Activation After Cuprizone-Induced Demyelination.

Klein B, Mrowetz H, Barker CM, Lange S, Rivera FJ, Aigner L.

Front Aging Neurosci. 2018 Sep 20;10:278. doi: 10.3389/fnagi.2018.00278. eCollection 2018.

44.

School Performance Paths: Personal and Contextual Factors Related to Top Performers and Low Achievers in Portugal and Spain.

Simões C, Rivera F, Moreno C, Matos MG.

Span J Psychol. 2018 Sep 24;21:E36. doi: 10.1017/sjp.2018.37.

PMID:
30246673
45.

Life Expectancies With Depression by Age of Migration and Gender Among Older Mexican Americans.

García C, Garcia MA, Chiu CT, Rivera FI, Raji M.

Gerontologist. 2019 Sep 17;59(5):877-885. doi: 10.1093/geront/gny107.

PMID:
30203062
46.

Single-Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial).

García-Alfonso P, Benavides M, Falcó E, Muñoz A, Gómez A, Sastre J, Rivera F, Montagut C, Salgado M, López-Ladrón A, López R, Ruiz de Mena I, Durán G, Aranda E; Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD).

Oncologist. 2018 Nov;23(11):1271-e128. doi: 10.1634/theoncologist.2018-0316. Epub 2018 Aug 17.

47.

First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: Phase II randomised MACRO2 TTD study.

Aranda E, García-Alfonso P, Benavides M, Sánchez Ruiz A, Guillén-Ponce C, Safont MJ, Alcaide J, Gómez A, López R, Manzano JL, Méndez Ureña M, Sastre J, Rivera F, Grávalos C, García T, Martín-Valadés JI, Falcó E, Navalón M, González Flores E, Ma García Tapiador A, Ma López Muñoz A, Barrajón E, Reboredo M, García Teijido P, Viudez A, Cárdenas N, Díaz-Rubio E; Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD).

Eur J Cancer. 2018 Sep;101:263-272. doi: 10.1016/j.ejca.2018.06.024. Epub 2018 Jul 24.

PMID:
30054049
48.

Relationships between tumour response and primary tumour location, and predictors of long-term survival, in patients with RAS wild-type metastatic colorectal cancer receiving first-line panitumumab therapy: retrospective analyses of the PRIME and PEAK clinical trials.

Peeters M, Price T, Taieb J, Geissler M, Rivera F, Canon JL, Pentheroudakis G, Koukakis R, Burdon P, Siena S.

Br J Cancer. 2018 Aug;119(3):303-312. doi: 10.1038/s41416-018-0165-z. Epub 2018 Jul 17.

49.

Retinal Pericytes: Characterization of Vascular Development-Dependent Induction Time Points in an Inducible NG2 Reporter Mouse Model.

Bruckner D, Kaser-Eichberger A, Bogner B, Runge C, Schrödl F, Strohmaier C, Silva ME, Zaunmair P, Couillard-Despres S, Aigner L, Rivera FJ, Reitsamer HA, Trost A.

Curr Eye Res. 2018 Oct;43(10):1274-1285. doi: 10.1080/02713683.2018.1493130. Epub 2018 Jul 18.

PMID:
29939774
50.

New Automatized Method of 3D Multiculture Viability Analysis Based on Confocal Imagery: Application to Islets and Mesenchymal Stem Cells Co-Encapsulation.

Chabert C, Laporte C, Fertin A, Tubbs E, Cottet-Rousselle C, Rivera F, Orhant-Prioux M, Moisan A, Fontaine E, Benhamou PY, Lablanche S.

Front Endocrinol (Lausanne). 2018 May 25;9:272. doi: 10.3389/fendo.2018.00272. eCollection 2018.

Supplemental Content

Loading ...
Support Center